Previous 10 | Next 10 |
Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.71. More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Nov. 7, 2018 SEATTLE and VANCOUVER, British Columbia , Nov. 7, 2018 /CNW/ -- Achieve ...
Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 Canada NewsWire SEATTLE, Wash. and VANCOUVER, British Columbia, Oct. 31, 2018 SEATTLE, Wash. and VANCOUVER, British Columbia , Oct. 31, 2018 /...
CORAL GABLES, FL / ACCESSWIRE / October 30, 2018 / According to the MarketsAndMarkets* report " Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management)...
Electro Scientific (NASDAQ: ESIO ) +87% on Q2 result . More news on: Electro Scientific Industries, Inc., Achieve Life Sciences, Inc., Differential Brands Group Inc., Stocks on the move, , Top stock market news, Read more ...
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 28% premarket on above-average volume in response to its launch of a Phase 2 clinical trial, ORCA-1 , evaluating cytisinicline (cytisine) for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks ...
SEATTLE and VANCOUVER, British Columbia , Oct. 30, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced initiation...
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more ...
Achieve Announces Pricing of $5.6 Million Registered Direct Offering Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Oct. 1, 2018 SEATTLE and VANCOUVER, British Columbia , Oct. 1, 2018 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical...
NEW YORK, NY / ACCESSWIRE / September 28, 2018 / Shares of biotech stocks Achieve Life Sciences and Acasti Pharma were both seeing big gains in Thursday's session. It was positive study results for Achieve that sent shares flying while Acasti moved on no news. RDI Initiates Coverage on: ...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...